Maile Alcos, APRN
Family · Kapolei, HINPI 1225418759
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,739 and has fallen 96.3% since, to $102 in 2025. Among family clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $27.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- AstraZeneca$506
- GSK$410
- Lilly USA, LLC$401
- Amgen$307
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,837100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $1,159 |
| AbbVie | 28 | $1,111 |
| AstraZeneca | 21 | $506 |
| GSK | 23 | $410 |
| Lilly USA, LLC | 23 | $401 |
| Amgen | 9 | $307 |
| Boehringer Ingelheim | 13 | $307 |
| Johnson & Johnson | 2 | $237 |
| Amarin Pharma, Inc. | 7 | $198 |
| Corcept Therapeutics | 4 | $183 |
| Esperion Therapeutics, Inc. | 3 | $165 |
| Kowa Pharmaceuticals America, Inc. | 7 | $155 |
| Bayer | 2 | $144 |
| E.r. Squibb & Sons, L.L.C. | 2 | $115 |
| Pfizer | 5 | $107 |
| Gilead | 5 | $107 |
| Novartis | 4 | $69 |
| Merck | 3 | $63 |
| Abbott | 1 | $58 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,855 in reported general payments places this provider in the 95th percentile of 466 family providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 43 | $616 |
| Losartan Potassium | 11 | $115 |
| Amlodipine Besylate | 25 | $103 |
| Metoprolol Succinate | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Other family in Kapolei
- Marife SolomonKapolei$8K
- Sho ParkKapolei$6K
- Malia HowardKapolei$3K
- Joey SesonHonolulu$48K
- Kanna DokgoHonolulu$26K
- John MosesHonolulu$24K
- Cecilia GreenWaipahu$21K
- Sherry Sutherland ChoyKahuku$21K
- Kristina HalloranAiea$12K
- Natalie KitamuraPearl City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.